Brought to you byInfluencer AdvisoryYour wellness & health influencer agency
Kenvue's own stated aim was to reduce complexity across its agencies, having already run a separate global influencer review a year earlier.
Somebody asserted the problem rather than a document recording it. Who said it, and whether they had a stake, is named below.
How we know
Kenvue's stated purpose for the review was to "reduce complexity, improve execution and accelerate growth". The outcome split media, influencer, commerce, healthcare professional support and technology to one holding company and creative to another.
| Who says so | Ad Age for the influencer line, Adweek and BestMediaInfo for the split. Adweek's own copy never uses the word influencer, so that detail rests on Ad Age. Read it |
|---|---|
| A second source | Adweek confirmed independently that Kenvue chose WPP and Publicis Groupe after a competitive review that began in the fall, and that Publicis oversees media, commerce, healthcare and technology plus creative and production for Neutrogena. Adweek's own copy does not use the word influencer; the influencer line comes from Ad Age and is repeated by BestMediaInfo, media-marketing.com and Ad Age's own social posts. |
| What the agency was asked to do | Not published as a quoted brief. On record: Publicis Groupe took media, influencer, commerce, healthcare professional support and technology for all Kenvue brands, plus creative and production for Neutrogena. WPP took creative and production for every other brand. |
| How the agency was picked | Competitive pitch |
| How that happened | Kenvue ran a global review of media, brand and production services that opened around 30 September 2025 and closed in December 2025. Adweek says the review was competitive and began earlier in the fall. WPP and Publicis Groupe split the outcome. Incumbents beyond Publicis, which already held Kenvue media in Asia Pacific, are not named. |
| How long it took | Review opened around 30 September 2025, outcome announced 22 December 2025, so about three months. Start date and contract length not published. The earlier global influencer agency review was reported 11 September 2024. |
| Recorded as | Kenvue (Tylenol, Listerine, Neutrogena, Band-Aid, Aveeno, Neosporin) |
Every other case where it had to run all year, not once →
← Every caseEvery case here carries the one link that proves it, and names who said it. Where that is the agency describing its own win, the card says so rather than hiding it. Cases where nobody ever documented a reason are not on this page at all. Brought to you by Influencer Advisory, your influencer marketing partner for supplement, health and beverage brands.